2009Journal of Regional Anatomy and Operative SurgeryRequires access

Clinical analysis of tripterygium wilfordii combined prostaglandin E1 in treatment of arteriosclerosis obliterans in lower extremity (report of 36 cases)

Kai Chen

Open publisher page 0 citations

Abstract

Objective To evaluate the therapeutic effect of tripterygium wilfordii combined prostaglandin E1(PGE1)in treatment of arteriosclerosis obliterans(ASO) in lower extremity. Methods Totally 72 patients with ASO were randomly divided into the treatment group(36 cases) and the control group(36 cases). The treatment group had been treated with tripterygium wilfordii combined PGE1 for 2 courses of treatment. The control group had been treated only with PGE1 for 2 courses of treatment. Therapeutic effect was compared. Results The total effective rate of the treatment group and the control group is 91.67% and 72.22% respectively. Two groups had significant differnce(P0. 01). Conclusion The therapeutic effect of tripterygium wilfordii combined PGE1 is superior to that of the PGE1 only in treatment of ASO in lower extremity. Further study should be carried out for its low price and abundant medicinal herbs.

About this research paper

What this paper is about

Objective To evaluate the therapeutic effect of tripterygium wilfordii combined prostaglandin E1(PGE1)in treatment of arteriosclerosis obliterans(ASO) in lower extremity. Methods Totally 72 patients with ASO were randomly divided into the treatment group(36 cases) and the control group(36 cases). The treatment group had been treated with tripterygium wilfordii combined PGE1 for 2 courses of treatment. The control group had been treated only with PGE1 for 2 courses of treatment. Therapeutic effect was compared. Results The total effective rate of the treatment group and the control group is 91.67% and 72.22% respectively. Two groups had significant differnce(P0. 01). Conclusion The therapeutic effect of tripterygium wilfordii combined PGE1 is superior to that of the PGE1 only in treatment of ASO in lower extremity. Further study should be carried out for its low price and abundant medicinal herbs.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the therapeutic effect of tripterygium wilfordii combined prostaglandin E1(PGE1)in treatment of arteriosclerosis obliterans(ASO) in lower extremity. Methods Totally 72 patients with ASO were randomly divided into the treatment group(36 cases) and the control group(36 cases). The treatment group had been treated with tripterygium wilfordii combined PGE1 for 2 courses of treatment. The control group had been treated only with PGE1 for 2 courses of treatment. Therapeutic effect was compared. Results The total effective rate of the treatment group and the control group is 91.67% and 72.22% respectively. Two groups had significant differnce(P0. 01). Conclusion The therapeutic effect of tripterygium wilfordii combined PGE1 is superior to that of the PGE1 only in treatment of ASO in lower extremity. Further study should be carried out for its low price and abundant medicinal herbs.

Key concepts: Tripterygium wilfordii, Medicine, Tripterygium, Arteriosclerosis obliterans, Therapeutic effect, Prostaglandin E1, Traditional medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical analysis of tripterygium wilfordii combined prostaglandin E1 in treatment of arteriosclerosis obliterans in lower extremity (report of 36 cases) — Research Paper | ScholarLens